Authors
Loading...
Randomized trial evaluates genomic alterations in T-cell malignancies associated with CAR T-cell therapy, suggesting important implications for patient management.
Park et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: